ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,180,000 | -73.9% | 589,311 | -47.2% | 1.35% | -78.0% |
| Q4 2021 | $31,298,000 | -17.4% | 1,115,411 | 0.0% | 6.14% | -12.5% |
| Q3 2021 | $37,913,000 | -16.8% | 1,115,411 | 0.0% | 7.02% | -11.9% |
| Q2 2021 | $45,576,000 | +1.5% | 1,115,411 | 0.0% | 7.97% | -9.8% |
| Q1 2021 | $44,906,000 | -31.9% | 1,115,411 | 0.0% | 8.83% | -41.0% |
| Q4 2020 | $65,954,000 | +21.6% | 1,115,411 | 0.0% | 14.96% | -3.1% |
| Q3 2020 | $54,242,000 | +0.5% | 1,115,411 | 0.0% | 15.44% | +3.7% |
| Q2 2020 | $53,964,000 | +74.2% | 1,115,411 | 0.0% | 14.89% | +43.0% |
| Q1 2020 | $30,986,000 | -7.2% | 1,115,411 | 0.0% | 10.41% | +9.8% |
| Q4 2019 | $33,373,000 | -3.2% | 1,115,411 | 0.0% | 9.48% | -27.4% |
| Q3 2019 | $34,466,000 | – | 1,115,411 | – | 13.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |